Dagim Jirata Berri

Dagim Jirata Berri


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
TBTesfaye Legesse Bedada
Tesfaye Legesse Bedada
TFTatek Kasim Feto
Tatek Kasim Feto
KAKaleab Sebsibe Awoke
Kaleab Sebsibe Awoke
ADAsnake Desalegn Desalegn
Asnake Desalegn Desalegn
FTFitsum Tigu Tigu
Fitsum Tigu Tigu
DBDagim Jirata Berri
Dagim Jirata Berri
Cancer is a fatal malignancy with high clinical significance and remains one of the major causes of illness and death. It has no suitable cure existing till now. The safety and stability of the standard chemotherapeutics drugs and synthetic agents used to manage cancer are doubtful. These agents are affecting the quality of life or contributing for development of drug resistance and are not affordable to the majority of the patients. Therefore, scientists are looking into clinical management of the cancer with high efficiency. This review focuses on the role of probiotics as alternative prevention and treatment of cancer. In this regard, we discuss the alternative cancer biotherapeutic drugs including live or dead probiotics and their metabolites, such as short chain fatty acids, inhibitory compounds of protein, polysaccharide, nucleic acid and ferrichrome in in vitro, in vivo and clinical studies. We also discuss the effectiveness of these biotherapeutics in prevention and treatment of various types of cancer linked with probiotic bacterial or fungal strains, probiotic dose, and time of exposure. More in vivo mainly clinical trials are necessary to further reveal and approve the significant role of live and dead probiotics as well as their metabolic products in cancer prevention and treatment. Finally, the majority of the positive results provided by probiotic treatments are limited to experimental settings. To minimize side effects associated with probiotics, short and long term effect studies in the direction of methodology standardization are required.

7 August 2023 in Microbial Pathogenesis
Verified
Journal Article
Closed access
GAGemechu Ameya
Gemechu Ameya
DBDagim Jirata Berri
Dagim Jirata Berri

1 June 2023 in Heliyon
Verified
Journal Article
Open access
MBMeseret Berhanu
Meseret Berhanu
ADAsnake Desalegn
Asnake Desalegn
DBDagim Jirata Berri
Dagim Jirata Berri
MAMogessie Ashenafi
Mogessie Ashenafi
FTFitsum Tigu Tigu
Fitsum Tigu Tigu
Tej is an Ethiopian traditional alcoholic beverage with significant social and economic importance. Due to the spontaneous fermentation process of Tej, several issues such as safety, quality, and physicochemical properties of the final products is rquired to be assessed. Thus, this study was aimed to assess the microbial quality, physicochemical, and proximate properties of Tej associated with different maturity time. The microbial, physicochemical and proximate analyses were carried out by standard protocol. Lactic acid bacteria (6.30 log CFU/mL) and yeast (6.22 log CFU/mL) were the dominat microorganisms of all Tej samples at different maturity time, with significant differences (p = 0.001) in mean microbial count among samples. The mean pH, titratable acidity and ethanol content of Tej samples were 3.51, 0.79 and 11.04% (v/v), respectively. There were significant differences (p = 0.001) among the mean pH and titratable acidity values. The mean proximate compositions (%) of Tej samples were as follows: moisture (91.88), ash (0.65), protein (1.38), fat (0.47) and carbohydrate (3.91). Statistically significant differences (p = 0.001) were observed in proximate compositions of Tej samples from different maturity time. Generally, Tej maturity time has a great impact on the improvement of nutrient composition and the increment of the acidic contents which in turn suppress the growth of unwanted microorganisms. Further evaluation of the biological, and chemical safety and development of yeast-LAB starter culture are strongly recommended to improve Tej fermentation in Ethiopia.

14 April 2020 in International Journal of Microbiology
Verified
Journal Article
Open access
PDF file
MSMargarete Alice Fontes Saraiva
Margarete Alice Fontes Saraiva
DBDagim Jirata Berri
Dagim Jirata Berri
DBDag Anders Brede
Dag Anders Brede
MBMaria Cristina Baracat-Pereira
Maria Cristina Baracat-Pereira
MQMarisa Vieira de Queiroz
Marisa Vieira de Queiroz
CMCélia Alencar de Moraes
Célia Alencar de Moraes
In this study, five bacteriocin-producingLactococcus lactisstrains were identified from different naturally fermented Brazilian sausages. Ion exchange and reversed-phase chromatographies were used to purify the bacteriocins from culture supernatant of the five strains. Mass spectrometry (MALDI-TOF/TOF) showed that the molecular masses of the bactericoins fromL. lactisID1.5, ID3.1, ID8.5, PD4.7, and PR3.1 were 3330.567 Da, 3330.514 Da, 3329.985 Da, 3329.561 Da, and 3329.591 Da, respectively. PCR product sequence analysis confirmed that the structural genes of bacteriocins produced by the five isolates are identical to the lantibiotic nisin Z. Optimal nisin Z production was achieved in tryptone and casein peptone, at pH 6.0 or 6.5. The most favorable temperatures for nisin Z production were 25°C and 30°C, and its production was better under aerobic than anaerobic condition. The type of carbon source appeared to be an important factor for nisin Z production. While sucrose was found to be the most efficient carbon source for nisin Z production by fourL. lactisisolates, fructose was the best for one isolate. Lactose was also a good energy source for nisin Z production. Surprisingly, glucose was clearly the poorest carbon source for nisin Z production. The five isolates produced different amounts of the bacteriocin,L. lactisID1.5 and ID8.5 isolates being the best nisin Z producers. DNA sequence analysis did not reveal any sequence differences in thenisZandnisFpromoter regions that could explain the differences in nisin Z production, suggesting that there should be other factors responsible for differential nisin Z production by the isolates.

1 January 2025 in International Journal of Microbiology
Verified
Journal Article
Open access
MSMinyilal Sisay
Minyilal Sisay
ADAsnake Desalegn Desalegn
Asnake Desalegn Desalegn
FTFitsum Tigu Tigu
Fitsum Tigu Tigu
MAMogessie Ashenafi
Mogessie Ashenafi
FBFeng-Yan Bai
Feng-Yan Bai
DBDagim Jirata Berri
Dagim Jirata Berri
Some members of the lactic acid bacteria (LAB) have been used as probiotics. Ethiopian honey wine, Tej , may be a useful source of potential probiotic bacteria. However, LABs from this source have not yet been evaluated for their probiotic properties. This study was conducted to evaluate the in vitro probiotic properties of LAB isolated from Ethiopian honey wine, Tej . For this purpose, 30 samples were collected from Southwest Ethiopia. LAB isolates were first tested for their antimicrobial activity and those with this property were evaluated for probiotic properties, such as tolerance to acid, salt, and bile, adherence properties, anticholesterol activity, antioxidant activity, and antibiotic susceptibility. The antibacterial activity of the LAB isolates against test organisms was assessed by the agar well diffusion method. Acid, salt, and bile tolerance were evaluated by the plate count method. Adhesion properties were assessed by the determination of bacterial hydrophobicity to the nonpolar solvent p‐xylene. Anticholesterol was determined by measuring the remaining cholesterol in the spent broth. The antioxidant capacity was assessed by the 1,1‐diphenyl‐2‐picrylhydrazyl free radical‐scavenging capacity, and the antibiotic susceptibility of isolates was tested by the disk diffusion method. A total of 143 LABs were isolated from Tej samples. The LAB count was ranged between 7.4 and 6.5 log cfu/mL. Of the 143 LAB isolates, 37 exhibited different levels of antimicrobial activity. Eight of these were identified to species level by 16S ribosomal genes sequence analysis. The greatest inhibition was against Shigella boydii ATCC 25931 with 19 ± 4.2 mm, and the least inhibitory activity was against Escherichia coli ATTC 25922 and Staphylococcus aureus ATTC 25913 with 8.0 ± 1.4. All except two isolates survived at pH 2 and pH 3 (18.4%–89.6%). Then, 37 isolates survived in more than 50% bile and 54%–67% adhesion capacity. The cholesterol‐lowering and 1,1‐diphenyl‐2‐picrylhydrazyl free radical‐scavenging capacities ranged from 8% to 54% and 13% to 33%, respectively. Most isolates were susceptible to antibiotics, except for one isolate that resisted all tested antibiotics. This study shows that many LABs isolated from Ethiopian honey wine, Tej have probiotic properties and they can be considered as probiotic candidates. We recommend evaluation of in vivo probiotic properties of the LAB isolates to provide strong supporting evidence.

21 May 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KHKedija Hayre
Kedija Hayre
MTMihiretu Kumie Takele
Mihiretu Kumie Takele
DBDagim Jirata Berri
Dagim Jirata Berri
Tuberculosis (TB) is a global public health problem. Evaluation of TB treatment outcome enables health institutions to measure and improve the effectiveness of TB control programs. This study aimed to assess treatment outcomes of tuberculosis and identify associated factors among TB patients registered at Alemgena Health Center, Oromia, Ethiopia. A retrospective study was conducted; Secondary data were collected from medical records of 1010 TB patients treated at Alemgena Health Center between September 2012 and August 2018, inclusively. Logistic regression was used to identify factors associated with TB treatment outcomes. P-value less than 0.05 was considered statistically significant. The proportion of males and females was almost equal. Among the patients 64.7% were in the age group 15–34, 98% were new cases, 31.2% were smear positive, 13% were HIV positive and 40.3% had extra-pulmonary tuberculosis. 94.2% of the patients had successful treatment outcome, with 26.9% cured and 67.3% treatment completed, whereas 5.8% had unsuccessful treatment outcomes, of whom 4.2% died and 1.5% defaulted. Death rate was higher among patients older than 44 years (10.4%) than among children (0%). In bivariate logistic regression analysis, treatment success rate was 3.582 (95% CI 1.958–6.554, p-value = .000) times higher in the age group 44 and below compared to the age group 45 and above. Treatment success rate exceeded the one targeted by WHO. Age was found to be associated with treatment outcome. Success rate has to be improved for TB patients in the age group greater than 45 years of age.